Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Jan;10(1):112-5.
doi: 10.4103/1735-3327.111812.

Ameloblastic fibrosarcoma of the upper jaw: Report of a rare case with long-term follow-up

Affiliations
Case Reports

Ameloblastic fibrosarcoma of the upper jaw: Report of a rare case with long-term follow-up

Maryam Khalili et al. Dent Res J (Isfahan). 2013 Jan.

Abstract

Ameloblastic fibrosarcoma (AFS) is a rare malignant mixed odontogenic tumor which is usually considered as the malignant counterpart of ameloblastic fibroma. Only mesenchymal component represents sarcomatous alterations and ameloblast-like epithelial nest remains bland in AFS. Here, we report a case of AFS in a 26-year-old man in the maxilla, which was regarded as an uncommon location for this tumor. After 2 years follow up, no evidence of recurrence was noted. We also emphasize on comprehensive clinical, radiographic, and histopathologic evaluation of such patients rather than immunohistochemical staining to make an accurate diagnosis.

Keywords: Ameloblastic fibrosarcoma; maxilla; odontogenic tumor.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared

Figures

Figure 1
Figure 1
Intraoral view shows buccal and palatal expansion in the left maxillary region and the exophytic ulcerated mass
Figure 2
Figure 2
Computed tomography scan shows extensive destruction of the left maxillary sinus
Figure 3
Figure 3
Photomicrographs showing (a) benign-appearing epithelial islands and highly cellular mesenchymal component (H and E, original magnification ×100); (b) pleomorphism and scattered bizarre cells in mesenchymal component (H and E, original magnification ×100)
Figure 4
Figure 4
Intraoral examination and (a) CT scan evaluation (b) revealed no evidence of recurrence after two years
Figure 5
Figure 5
Age and gender distribution of 68 cases of Ameloblastic fibrosarcoma (age or gender of three cases of 71 reported AFSs have not been specified)

Similar articles

Cited by

References

    1. Bregni RC, Taylor AM, Garcia AM. Ameloblastic fibrosarcoma of the mandible: Report of two cases and review of the literature. J Oral Pathol Med. 2001;30:316–20. - PubMed
    1. Lee OJ, Kim HJ, Lee BK, Cho KJ. CD34 expressing ameloblastic fibrosarcoma arising in the maxilla: A new finding. J Oral Pathol Med. 2005;34:318–20. - PubMed
    1. Pontes HA, Pontes FS, Silva BS, Cury SE, Fonseca FP, Salim RA, et al. Immunoexpression of Ki67, proliferative cell nuclear antigen, and Bcl-2 proteins in a case of ameloblastic fibrosarcoma. Ann Diagn Pathol. 2010;14:447–52. - PubMed
    1. Demoor-Goldschmidt C, Minard-Colin V, Cassagneau E, Supiot S, Oberlin O, D’Hautuille C, et al. Ameloblastic fibrosarcoma of the mandible: Report of 2 chemosensitive pediatric cases. J Pediatr Hematol Oncol. 2011;34:e72–6. - PubMed
    1. Williams MD, Hanna EY, El-Naggar AK. Anaplastic ameloblastic fibrosarcoma arising from recurrent ameloblastic fibroma: Restricted molecular abnormalities of certain genes to the malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:72–5. - PubMed

Publication types

LinkOut - more resources